VT Foreign Policy
All links to previous Gospa News articles were added retrospectively due to their relevance to the topics covered by the research.
«This report highlights the role of the different types of autoantibodies produced in response to anti-COVID-19 vaccination, which can have functional, regulatory, and possibly pathogenic effects on the vascular and nervous systems».
This is the crucial sentence of a study published on May 10, 2024, by the prestigious medical journal Cureus of Springer Nature, based in San Francisco, California (USA), after a review of about three weeks of the research that Gospa News had relaunched in previewed on April 23rd due to its relevance.
The work is signed by Italian researchers such as the immunologist Mauro Mantovani and his colleagues Romano Grossi, from the Nephrology and Dialysis department of the “S.M. Goretti” of Latina, Giuseppe Di Fede, medical director of the Institute of Biological Medicine of Milan (where Mantovani himself, the first signatory, works) and Paolo Bellavite, corresponding author and former professor of General Pathology at the University of Padua.
«We present the case of a female who developed cerebral venous thrombosis with thrombocytopenia after inoculation with the anti-coronavirus disease 2019 (COVID-19) Vaxzevria vaccine, followed by splanchnic thrombosis and diffuse hemorrhages. Despite receiving treatment, the complications increased, and hence therapeutic plasma exchange (TPE) was attempted, leading to laboratory and clinical improvements and discharge after a period of intensive care» the doctors write in the summary of AstraZeneca’s mDNA gene serum research.
Over the past few days, London-based Big Pharma AstraZeneca has also admitted the risk of fatal thrombosis caused by its anti-Covid mDNA gene serum, but has defined them as “rare” despite Eudravigilance pharmacovigilance adverse reaction data in the EU reporting hundreds of deaths.
The pharmaceutical company also announced the withdrawal of the marketing authorization from the European Union with a maneuver that was more media-driven than real as its vaccine had not already been sold for 2 years and the product has not yet been withdrawn in the United Kingdom.
Epilepsy and Long Post-COVID Vaccination Syndrome (LPCVS)
«Almost two years after the first episode, in the interim of which the patient complained of only minor symptoms such as asthenia and difficulty concentrating, she developed an epileptic syndrome that required neurological treatment. In addition, her fatigue and difficulty concentrating worsened and other serious symptoms of dysautonomia appeared, such as trembling of her right arm, loss of stability, and postural orthostatic tachycardia. As serum analysis revealed a significant number of alterations in autoantibodies against various G-protein-coupled receptors (GPCRs) and RAS-related proteins, two further TPEs were performed, resulting in rapid and sustained clinical improvement».
This is what we read in the peer-reviewed abstract of the study.
The research of Mantovani, already author of the discovery of Double Proline inserted in vaccines which aggravates the persistence of the toxic Spike protein, and Bellavite, who had already published a study on autoimmune problems, represents a milestone in the discovery of the biochemical mechanism that can cause very serious neurological and cardiovascular damage already highlighted by multiple international research…
READ FULL ARTICLE HERE… (vtforeignpolicy.com)
Home | Caravan to Midnight (zutalk.com)
